Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Minimal Change Disease and Focal Segmental Glomerulosclerosis are associated with good kidney prognosis and Thrombotic Microangiopathy with poor kidney survival in patients with COVID-19-associated nephropathies.
Neves PDMM, Araujo SA, Wanderley DC, Sodré AM, Campos MAG, Watanabe EH, Malheiros DMAC, Cavalcante LB, Ledesma FL, Israel KCP, Barcelos FLB, Pinho LLF, Barbosa FAM, Miranda SMC, Dantas M, Britto WLM, Paixão JO, Madeira RL, Guedes FL, Luchi WM, Cuvello-Neto AL, Marques IDB, Almeida JB, Vasco RFV, Monteiro A, Ladchumananandasivam FR, Júnior AALT, Gomes OV, Hagemann R, Ferra-Neto OA, Santos RF, Costa DMDN, Luz-Neto ER, Soares LCBA, Mubarac RS, Costa KMAH, Weissheimer R, Almeida CM, Silva BABD, Miranda LS, Iannuzzi LR, Murata GM, Noronha IL, Salgado Filho N, Onuchic L, Silva GEB. Neves PDMM, et al. Among authors: noronha il. Am J Nephrol. 2024 Dec 11:1-29. doi: 10.1159/000542836. Online ahead of print. Am J Nephrol. 2024. PMID: 39662073 Free article.
Endothelin receptor antagonists in chronic kidney disease.
Smeijer JD, Kohan DE, Dhaun N, Noronha IL, Liew A, Heerspink HJL. Smeijer JD, et al. Among authors: noronha il. Nat Rev Nephrol. 2024 Dec 6. doi: 10.1038/s41581-024-00908-z. Online ahead of print. Nat Rev Nephrol. 2024. PMID: 39643698 Review.
Focal Segmental Glomerulosclerosis Patient Baseline Characteristics in the Sparsentan Phase 3 DUPLEX Study.
Trachtman H, Radhakrishnan J, Rheault MN, Alpers CE, Barratt J, Heerspink HJL, Noronha IL, Perkovic V, Rovin B, Trimarchi H, Wong MG, Mercer A, Inrig J, Rote W, Murphy E, Bedard PW, Roth S, Bieler S, Komers R. Trachtman H, et al. Among authors: noronha il. Kidney Int Rep. 2024 Jan 28;9(4):1020-1030. doi: 10.1016/j.ekir.2024.01.032. eCollection 2024 Apr. Kidney Int Rep. 2024. PMID: 38765567 Free PMC article.
Capacity for the management of kidney failure in the International Society of Nephrology Latin America region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA).
Calice-Silva V, Neyra JA, Ferreiro Fuentes A, Singer Wallbach Massai KK, Arruebo S, Bello AK, Caskey FJ, Damster S, Donner JA, Jha V, Johnson DW, Levin A, Malik C, Nangaku M, Okpechi IG, Tonelli M, Ye F, Madero M, Tzanno Martins C; Regional Board and ISN-GKHA Team Authors. Calice-Silva V, et al. Kidney Int Suppl (2011). 2024 Apr;13(1):43-56. doi: 10.1016/j.kisu.2024.01.001. Epub 2024 Apr 8. Kidney Int Suppl (2011). 2024. PMID: 38618500 Free PMC article. Review.
Idiopathic collapsing glomerulopathy is associated with APOL1 high-risk genotypes or Mendelian variants in most affected individuals in a highly admixed population.
Neves PD, Watanabe A, Watanabe EH, Narcizo AM, Nunes K, Lerario AM, Ferreira FM, Cavalcante LB, Wongboonsin J, Malheiros DM, Jorge LB, Sampson MG, Noronha IL, Onuchic LF. Neves PD, et al. Among authors: noronha il. Kidney Int. 2024 Mar;105(3):593-607. doi: 10.1016/j.kint.2023.11.028. Epub 2023 Dec 22. Kidney Int. 2024. PMID: 38143038
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Among authors: noronha il. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
129 results